Translation from clinical trials to routine practice: How to demonstrate community benefit

Asia-Pacific Journal of Clinical Oncology

Volumn 11, Issue 1, 2015, Pages 1-3

  Roder, David ^a   Buckley, Elizabeth ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; BREAST CANCER; CANCER PATIENT; CANCER REGISTRY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); COMORBIDITY; DATA BASE; EDITORIAL; GOVERNMENT; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; INFORMATION PROCESSING; MEDICAL SPECIALIST; METASTATIC COLORECTAL CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); CANCER STAGING; COLORECTAL NEOPLASMS; FEMALE; MALE;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;

EID: 84921653961     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12338     Document Type: Editorial

References (27)

1. Lok SW, Wong H-L, Kosmider S etal. Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practice. Asia Pac J Clin Oncol 2014; 10: 361-367.
2. Hurwitz H, Fehrenbacher L, Novotny W etal. Bevacizumab plus irinotecan, fluoracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.
3. Van Cutsem E, Kohne CH, Hitre E etal. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009; 360: 1408-1417.
4. Van Cutsem E, Peeters M, Siena S etal. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol 2007; 25: 1658-1664.
5. Elting LS, Cooksley C, Bekele BN etal. Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. Cancer 2006; 106: 2452-2458.
6. Meyer RM. Generalizing the results of cancer clinical trials. J Clin Oncol 2010; 28: 187-189.
7. Baker SG, Kramer BS. Randomized trials, generalizability, and meta-analysis: graphical insights for binary outcomes. BMC Med Res Methodol 2003; 16: 10.
8. McNeil JJ, Evans SM, Johnson NP, Cameron PA. Clinical-quality registries: their role in quality improvement. Med J Aust 2010; 192: 244-245.
9. Valery P. Cancer in Aboriginal and Torres Strait Islander people in Queensland. The Lowitja Institute, Brisbane, 2012.
10. Cancer Institute NSW (CINSW). Information sheet: Australian Prostate Cancer Clinical Registry (APCCR). CINSW, Sydney, 2014.
11. Breast Surgeons of Australia and New Zealand. BreastSurgANZ quality audit. Royal Australasian College of Surgeons, Adelaide, 2011.
12. National Health and Medical Research Council (NHMRC). Inclusion of Advice on an opt-out approach - National Statement, 2007 (Chapter 2.3). NHMRC, Canberra, November 2014.
13. Australian Commission on Safety and Quality in Health Care (ACSQHC). A framework for Australian clinical quality registries. ACSQHC, Sydney, 2015.
14. White V, Pruden M, Giles G etal. The management of early breast carcinoma before and after the introduction of clinical practice guidelines. Cancer 2004; 101: 476-485.
15. McGrath DR, Leong DC, Armstrong BK, Spigelman AD. Management of colorectal cancer patients in Australia: the National Colorectal Cancer Care Survey. ANZ J Surg 2004; 74: 55-64.
16. Roder DM, Fong KM, Brown MP, Zalcberg J, Wainwright CE. Realising opportunities for evidence-based cancer service delivery and research: linking cancer registry and administrative data in Australia. Eur J Cancer Care 2014; 23: 721-727.
17. Beckmann KR, Bennett A, Young GP, Roder DM. Treatment patterns among colorectal cancer patients in South Australia: a demonstration of the utility of population-based data linkage. J Eval Clin Prac 2014; 20: 467-477.
18. Jorgensen ML, Young JM, Dobbins TA, Solomon MJ. Predictors of variation in colorectal cancer care and outcomes in New South Wales: a population-based health data linkage study. Med J Aust 2014; 200: 403-407.
19. Smith RC, Creighton N, Lord RV etal. Survival, mortality and morbidity outcomes after oesophogastric cancer surgery in New South Wales, 2001-2008. Med J Aust 2014; 200: 408-413.
20. Currow D, You H, Aranda S etal. What factors are predictive of surgical resection and survival from localised non-small cell lung cancer? Med J Aust 2014; 201: 475-480.
21. Beaton J, Carey S, Solomon MJ, Tan KK, Young J. Preoperative body mass index, 30-day postoperative morbidity, length of stay and quality of life in patients undergoing pelvic exenteration surgery for recurrent and locally-advanced rectal cancer. Ann Coloproctol 2014; 30: 83-87.
22. Olver IN. Linking data to improve health outcomes. Routinely collected data, when linked, are a rich source of sound evidence for making health care decisions. Med J Aust 2014; 200: 368-369.
23. Royal College of Pathologists of Australasia (RCPA). Structured pathology reporting of cancer. RCPA, Sydney, 2014.
24. Western Australian Department of Health. Data Linkage, Western Australia. Enabling health and medical research in Western Australia. Government of Western Australia, Perth, 2014.
25. Population Health Research Network (PHRN). Australian data linkage units. PHRN, Perth, 2011.
26. Sax Institute. SURE - Secure Unified Research Environment. Sydney: Sax Institute, 2014.
27. Australian Government, Australian Institute of Health and Welfare (AIHW). BreastScreen Australia Monitoring Report 2011-2012. Cancer Series No. 86. Cat. No. CAN 83. AIHW, Canberra, 2014.